MHRA updates safety warnings for common antidepressants
Summarised from Gloucestershire Live's report · Updated 11 Nov, 15:28 · Archive
The medicines regulator has updated information for users of sertraline, fluoxetine and citalopram about sexual side effects.
The MHRA has updated safety information for users of common antidepressants following reports that sexual side effects can sometimes continue after treatment ends. Palvinder Deol, Superintendent Pharmacist at Happy Pharmacy, explained that medicines such as sertraline, fluoxetine and citalopram can affect sex drive and sexual sensation, with some people experiencing lasting problems. These continuing symptoms are sometimes referred to as post-SSRI sexual dysfunction, or PSSD.
Deol advised that people should not suddenly stop taking antidepressants because of the warning, as these medications remain an important part of treating mental health conditions. The exact prevalence of lasting sexual side effects is not yet known. Anyone who has noticed changes in their sexual health, whether still taking antidepressants or after stopping them, should speak to their GP or pharmacist.

Read the report
- Pharmacist 'symptoms continue' warning for sertraline, fluoxetine and citalopramThe advice comes as the regulator updates its information for usersGloucestershire Live · 11 Nov, 12:29
In this story: MHRA · Palvinder Deol · Happy Pharmacy
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)